Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-06

Clinical Trial Update: Influence of Dexmedetomidine or Propofol on ICU Delirium [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the impact of dexmedetomidine versus propofol on intensive care unit delirium was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • PROPOFOL (Propofol)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Delirium | Phase 4 | Status: TERMINATED